alexa Impact on B-Cell Chronic Lymphocytic Leukemia

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Impact on B-Cell Chronic Lymphocytic Leukemia

CD26 or Dipeptidyl peptidase IV (CD26/DPPIV) is a unique multifunctional 110 kDa membrane-bound glycoprotein, belongs to the serine protease family, acts as receptor, binding and proteolytic molecule. The crystal structure indicates that tetramerization of DP IV is a key mechanism to regulate its interaction with other components.

Citation: Ghannam DME, Taalab MM, Ghazy HF, Salam EMA, Fawzy IM (2014) CD26 Expression in Mature B-cell Neoplasms and its Prognostic Impact on B-Cell Chronic Lymphocytic Leukemia. J Blood Disorders Transf 5:222. doi: 10.4172/2155-9864.1000222
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger